Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Interpolation2on Sep 21, 2017 10:57am
66 Views
Post# 26725512

RE:New extraction technology

RE:New extraction technologyXXII being doing this for some time and in fact they use the labs at UBC (Anandia).  XXII share price of course has gone from $0.88 to >$3.30 in no time.  XXII also has several patents.  I own ISOL and I am long (in fact from back when LAG was $0.09-$0.10).

jb24 wrote: Sooooo,
if ISOL can extract cannabinoids from other sources--------what happens to all other MJ  plays ----who extract cannibinoids------the old fashion way, the hard way, the expensive way (from farming MJ)??????????
GLTA


Isodiol International Inc (CSE: ISOL, OTCQB: ISOLF, Forum) announced today that it has launched a new Phytoceutical Division. The focus of this new branch will be cannabinoids and terpenes derived from non-cannabis sources.
Read more at https://www.stockhouse.com/news/newswire/2017/09/05/cannabis-company-reports-new-non-cannabis-cannabinoid-research#SUE2JT4KIHEQCyJW.99


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities